5-(chlorosulfonyl)-2-fluoro-3-methylbenzoic acid
Structure Info
- Chemspace ID
- CSCS00000689030 (Synthesis)
- CAS
- 1394040-67-5
- MFCD
- MFCD22378716
- IUPAC Name
- 5-(chlorosulfonyl)-2-fluoro-3-methylbenzoic acid
- Mol formula
- C8H6ClFO4S
- Mol weight
- 253 Da
- Catalog Number(s)
- A1015005, AR01A14W, AV46548, BB4LS-EN300-109859, BBV-40364976, BD00962708, C610523, CSC000689030, EN300-109859, UFC04067, Y3132428, ZXC290340
- Dangerous substance
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.23
- Heavy atoms count
- 15
- Rotatable bond count
- 2
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.125
- Polar surface area (Å)
- 71
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS00000689030
Items Overall 11 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 50 mg | 265 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 100 mg | 388 | |
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 250 mg | 549 | |
Description: Name:5-(Chlorosulfonyl)-2-fluoro-3-methylbenzoic acid; CAS: 1394040-67-5 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 50 mg | 265 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 100 mg | 388 | |
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 250 mg | 549 | |
Description: Name:5-(Chlorosulfonyl)-2-fluoro-3-methylbenzoic acid; CAS: 1394040-67-5 | ||||||
| eNovation CN | 40 days | China To: | 95 | 50 mg | 385.25 | |
| eNovation CN | 40 days | China To: | 95 | 100 mg | 563.5 | |
| eNovation CN | 40 days | China To: | 95 | 250 mg | 782 | |
| eNovation CN | 40 days | China To: | 95 | 500 mg | 1224.75 | |
| eNovation CN | 40 days | China To: | 95 | 1 g | 1569.75 | |
Description: 5-(chlorosulfonyl)-2-fluoro-3-methylbenzoic acid; CAS: 1394040-67-5 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire